ArticlePharmacoepidemiology and drug safety2026

Evaluating Data Quality by Proxy: Can We Evaluate All Dimensions of the European Medicines Agency Data Quality Framework for Registry-Based Post-Authorization Safety Studies?

Pamela Dobay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.